# 2-HOBA Phase 2 Clinical Trial in Rheumatoid Arthritis

> **NCT05274243** · PHASE2 · COMPLETED · sponsor: **Vanderbilt University Medical Center** · enrollment: 32 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** 2-HOBA
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05274243
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-09
- **Primary completion:** 2025-05-28
- **Final completion:** 2025-05-28
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05274243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05274243, "2-HOBA Phase 2 Clinical Trial in Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05274243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*